CTSK and neoplasm: To investigate the mechanism with which Lkb1 deletion induces the osteogenic tumor from Ctsk-Cre–positive periosteal mesenchymal stem cells, we focused on the mTORC1 pathway, which is a critical target downstream of LKB1-dependent AMP kinases (AMPKs).